MiMedx Group Inc (MDXG)
MiMedx Group is a placental biologics company, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. Co. is focused on wound care, surgical recovery applications, and musculoskeletal conditions. Co. derives its products from human placental tissues and process these tissues using its proprietary methods, including the PURION® process. Co. provides products primarily for use in the wound care, burn, and surgical recovery sectors of healthcare. Co. is a supplier of human placental allografts, which are human tissues that are derived from the donor and used to produce products that treat the recipient.
MDXG SEC Filing Email Alerts Service
| Company Name: |
MiMedx Group Inc |
| Stock buyback: |
MDXG buyback |
| Website: |
www.mimedx.com |
| Sector: |
Biotechnology |
| Number of ETFs Holding MDXG: |
20 |
| Total Market Value Held by ETFs: |
$86.87M |
| Total Market Capitalization: |
$971.00M |
| % of Market Cap. Held by ETFs: |
8.95% |
|
|
April 16, 2024 • 9:37 AM Eastern
Strong Buy (4.00 out of 4)
86th percentile
|
|
Free MDXG Email Alerts:
